We are pleased to share the progress MediBloc has made as we move through the first quarter of 2025. Our team has been focused on optimizing Panacea’s stability and performance, strengthening key partnerships, and expanding the utility of the MED token. With these efforts, we are building a more efficient and interconnected healthcare ecosystem.
Panacea Development Status
Panacea is continuously monitored and optimized to ensure stable network operations. Our team proactively checks the network’s status in real time, addressing potential issues before they arise and implementing various performance enhancements. We remain committed to improving Panacea to provide a more reliable and efficient network for Med holders.
Panacea Business Achievements
To expand the utility of MED tokens, we are pursuing various strategic initiatives. Given the limitations of operating solely on our Cosmos-based chain, we are working towards enabling cross-chain transactions through IBC (Inter-Blockchain Communication). This will allow MED tokens to move freely across different blockchain ecosystems. Additionally, we are supporting the formation of MED swap pools on external DEXs and exploring integrations with real-world services such as gift certificates to broaden the token’s use cases. These efforts are being carried out in collaboration with external partners, requiring careful coordination and preparation. We will continue striving to enhance the utility of MED tokens across diverse platforms.
Partner Collaboration Update : EMR Promotion Partnership with Weavrcare and Handok
Weavrcare, a valued partner of MediBloc, and Handok (Pharmaceutical company in South Korea) signed a joint promotion agreement on March 10, 2025 for the marketing and sales of the cloud-based EMR solution, Dr.palette. Developed by Weavrcare using Panacea’s blockchain technology, Dr.palette offers a seamless experience without the need for installation or manual updates. It integrates essential features for hospital management, such as data security, operational analytics, and customer relationship management. With Handok’s extensive experience in the pharmaceutical business and strong medical network, this partnership is expected to accelerate Dr. Palette’s market expansion.
Partner Collaboration Update : Strategic Partnership Between Weavrcare and Global Tax Free
On March 18, 2025 Weavrcare, a key partner of MediBloc, entered into a strategic partnership with Global Tax Free (GTF) to integrate medical data solutions. Through this agreement, Weavrcare will develop GTF’s refund service system through Dr.palette. In return, GTF will provide relevant data and promote cross-introduction of services to affiliated businesses. A key initiative of this partnership is the development of a TRH (Tax Refund Hospital) issuance system, enabling seamless tax refund services for international patients. This integration is expected to enhance the digital transformation of medical tourism, boost Dr. Palette’s competitiveness, and improve both hospital workflow efficiency and patient satisfaction.
3rd Party Service Update: Dr.palette Reaches 350 Partner Hospitals and Showcases at the ASLS
Weavrcare, a valued partner of MediBloc, recently participated in the Korean Aesthetic Surgery & Laser Society(ASLS) conference, promoting its cloud-based EMR solution, Dr.palette. Attendees had the opportunity to experience new features such as the planner tool, ticket/point system, and voice recording/timer functions. Developed with Panacea’s blockchain technology, Dr. Palette has now reached 350 partner hospitals, demonstrating strong interest and demand within the medical community. The solution is rapidly gaining adoption in primary care institutions due to its user-friendly interface and comprehensive features that enhance operational efficiency and patient management.
We remain dedicated to driving innovation and expanding the adoption of Panacea-powered solutions. Stay tuned for more updates!